Maternal and procedural factors associated with estimated blood loss in second trimester surgical uterine evacuation: a retrospective cohort analysis.
Health care access
Hemorrhage
Legal abortion
Surgical blood loss
Therapeutic abortion
Journal
International journal of obstetric anesthesia
ISSN: 1532-3374
Titre abrégé: Int J Obstet Anesth
Pays: Netherlands
ID NLM: 9200430
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
26
06
2019
revised:
06
02
2020
accepted:
01
03
2020
pubmed:
29
3
2020
medline:
26
8
2021
entrez:
29
3
2020
Statut:
ppublish
Résumé
Prior studies examining bleeding with uterine evacuation have focused on high-volume centers performing over 1100 procedures annually. The aim of this study was to examine associations between blood loss and patient and procedural characteristics in a center performing fewer than 50 procedures annually. This retrospective cohort study, with institutional review board approval, utilized procedural codes to identify patients undergoing uterine evacuation procedures between 14 weeks' and 24 weeks' gestational age across a 50-month period. The primary outcome was estimated blood loss; secondary outcomes were hemorrhage, transfusion and hospital re-admission. Associations between blood loss and other variables were examined using linear regression models. Charts of 161 women met inclusion criteria. Median estimated blood loss was 400 mL (IQR 300 mL) with 37% of patients having blood loss of ≥500 mL. In univariate analyses, increased blood loss was associated with later gestational age (P <0.001) and pregnancy termination (P <0.001). In a multiple linear regression model, both remained significant. Each one-week increase in gestational age was associated with a 7.1% mean increase in estimated blood loss (95% CI 2.47% to 11.9%; P=0.003). Patients whose uterine evacuation was indicated for pregnancy termination had an 80.6% increase in blood loss compared with those with pre-operative fetal demise (95% CI 37.5% to 137.2%; P <0.001). Rates of peri-operative transfusion and re-admission for bleeding were <4%. While blood loss may be greater in low volume centers, our transfusion and re-admission rates were low following second trimester uterine evacuation.
Sections du résumé
BACKGROUND
Prior studies examining bleeding with uterine evacuation have focused on high-volume centers performing over 1100 procedures annually. The aim of this study was to examine associations between blood loss and patient and procedural characteristics in a center performing fewer than 50 procedures annually.
METHODS
This retrospective cohort study, with institutional review board approval, utilized procedural codes to identify patients undergoing uterine evacuation procedures between 14 weeks' and 24 weeks' gestational age across a 50-month period. The primary outcome was estimated blood loss; secondary outcomes were hemorrhage, transfusion and hospital re-admission. Associations between blood loss and other variables were examined using linear regression models.
RESULTS
Charts of 161 women met inclusion criteria. Median estimated blood loss was 400 mL (IQR 300 mL) with 37% of patients having blood loss of ≥500 mL. In univariate analyses, increased blood loss was associated with later gestational age (P <0.001) and pregnancy termination (P <0.001). In a multiple linear regression model, both remained significant. Each one-week increase in gestational age was associated with a 7.1% mean increase in estimated blood loss (95% CI 2.47% to 11.9%; P=0.003). Patients whose uterine evacuation was indicated for pregnancy termination had an 80.6% increase in blood loss compared with those with pre-operative fetal demise (95% CI 37.5% to 137.2%; P <0.001). Rates of peri-operative transfusion and re-admission for bleeding were <4%.
CONCLUSION
While blood loss may be greater in low volume centers, our transfusion and re-admission rates were low following second trimester uterine evacuation.
Identifiants
pubmed: 32216983
pii: S0959-289X(20)30032-7
doi: 10.1016/j.ijoa.2020.03.001
pmc: PMC7363525
mid: NIHMS1572785
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
65-71Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Obstet Gynecol. 2019 Oct;134(4):708-713
pubmed: 31503145
CMAJ. 2019 May 13;191(19):E519-E528
pubmed: 31085561
Contraception. 2006 Apr;73(4):420-30
pubmed: 16531179
Sex Reprod Health Matters. 2019 Nov;27(3):1688917
pubmed: 31823692
Obstet Gynecol. 2010 Apr;115(4):760-4
pubmed: 20308836
Contraception. 2015 Jun;91(6):488-94
pubmed: 25746057
Contraception. 2013 Mar;87(3):331-42
pubmed: 23218863
Contraception. 2006 Sep;74(3):272-6
pubmed: 16904423
J Public Health Policy. 2012 Aug;33(3):348-62
pubmed: 22622483
Lancet Public Health. 2017 Nov;2(11):e493-e500
pubmed: 29253373
JAMA. 2018 Jun 26;319(24):2497-2506
pubmed: 29946727
Ann Surg. 2016 Apr;263(4):664-72
pubmed: 26636243
Obstet Gynecol. 2011 Feb;117(2 Pt 1):307-16
pubmed: 21252744
J Bone Joint Surg Am. 2017 Oct 18;99(20):1753-1759
pubmed: 29040130
Contraception. 2016 Nov;94(5):496-498
pubmed: 27343749
J Am Coll Surg. 2017 Nov;225(5):666-675.e2
pubmed: 28838870
Obstet Gynecol. 2015 Sep;126(3):585-92
pubmed: 26244536
Contraception. 2018 May;97(5):451-455
pubmed: 29410259